Cointime

Hongyun Biotech

company

About

Hongyun Biotech is a biotech company that promotes therapeutic innovation based on structural pharmacology.

  • Nanjing,Jiangsu,China

Highlights

Total Funding Amount
¥170M
Funding Rounds
3
Investors
5
Employee Profiles
4

Details

Last Funding Type
Series B
Last Funding Money Raised
¥100M
Industries
Biotechnology,Therapeutics
Founded date
Jan 1, 2018
Operating Status
Active
Legal Name
Hongyun Biotech Co. Ltd.
Also Known As
Red Cloud Bio,Nanjing Hongyun Biotechnology

Hongyun Biotech is a biotech company that promotes therapeutic innovation based on structural pharmacology.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
¥170M
Hongyun Biotech has raised a total of ¥170M in funding over 2 rounds. Their latest funding was raised on Jul 27, 2021 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 27, 2021 Series B ¥100M 5 — — Detail
Feb 28, 2020 Series A ¥50M 2 — — Detail
Jun 1, 2018 Angel ¥20M 1 Sherpa Venture Capital — Detail

Investors

Number of Lead Investors
Number of Investors
1
5
Hongyun Biotech is funded by 5 investors. DaYou Capital and Cowin Venture are the most recent investors.
Investor Name Lead Investor Funding Round
DaYou Capital — Series B
Cowin Venture — Series B
Dynamic Balance Capital — Series B
Kaitai Capital — Series B
Sherpa Venture Capital — Series B

Employee Profiles

Number of Employee Profiles
4
Hongyun Biotech has 4 current employee profiles, including Board member Cheng Xing
Cheng Xing
Board member
Xin Huang
Executive
Jianming Zhang
Executive
Yuanbin Sang
Board member
Cointime
Chủ Đề
Công Ty